Literature DB >> 29972349

Liver involvement is associated with blood culture positivity and high agglutination titre in patients with brucellosis in Turkey.

Huseyin Sahinturk1, Bulent Baran2, Gurhan Sisman3, Reskan Altun3.   

Abstract

We investigated the incidence of and risk factors for liver involvement (LI) in patients with brucellosis in Turkey. Diagnosis was established by blood cultures (BCs) or compatible clinical presentation accompanied by serological evidence. Patients received either a combination of doxycycline plus rifampin for 6 weeks or doxycycline for 6 weeks plus streptomycin intramuscularly for the first 2 weeks. Liver function tests, including those for alanine (ALT) and aspartate aminotransferase (AST) levels, were monitored before and at the end of treatment. One hundred and ninety-five patients were included in the study. Seventy patients had elevated transaminases before treatment. Twenty-six patients had a positive BC for brucellosis. In multivariate analysis, BC positivity (OR=2.44, 95 % CI: 1.03-5.78, P=0.043) and serum agglutination titre (SAT) (OR=1.001, 95 % CI: 1.00-1.002, P=0.018) were found to be associated with LI. Serum aminotransferase levels were normalized in all patients with brucellosis. BC positivity and high SAT are independent factors that are associated with LI in patients with brucellosis.

Entities:  

Keywords:  Brucella agglutination titre; blood culture; brucellosis; hepatitis; transaminases

Mesh:

Substances:

Year:  2018        PMID: 29972349     DOI: 10.1099/jmm.0.000791

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  2 in total

1.  Investigation of the Sensitivity and Specificity of Laboratory Tests Used in Differential Diagnosis of Childhood Brucellosis.

Authors:  Halil Kazanasmaz; Süleyman Geter
Journal:  Cureus       Date:  2020-01-23

2.  Demographic, Laboratory, and Clinical Comparison of Pediatric Brucella Cases With and Without Liver Involvement.

Authors:  Mehmet Agin; Yusuf Kayar
Journal:  Cureus       Date:  2020-10-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.